ENAVATE SCIENCES GP, LLC
CIK
1953107
Location
New York, NY
Portfolio Value
Small
$351,507,327
Diversification
Moderately concentrated
Filing Date
Global Rank
#3,158
/ 8,604
▼ 508
· as of Mar 2026
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+64.1%
Period ended 3 months ago
Filed May 15, 2026 · 54d
6 quarters · since Dec 2024
Clone Performance
Feb 2025–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+131.8%
SPY
+24.4%
Annualised alpha
+65.9%
Max drawdown
−42.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
7 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
28.3%
+0.2 pts
Top 5
91.0%
+1.1 pts
Top 10
100.0%
0.0 pts
HHI
2,009
Moderately concentrated+110
Portfolio Trend
6 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $351,507,327 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
7 positions ·
$351,507,327 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Held | 2,478,030 | $99,344,222 | 28.26% | |
| IMNM |
Immunome Inc.
Healthcare
|
Reduced | 3,613,799 | $79,033,784 | 22.48% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
Held | 3,919,159 | $76,619,558 | 21.80% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Held | 7,788,150 | $41,199,313 | 11.72% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
Held | 2,626,946 | $23,511,166 | 6.69% | |
| UPB |
Upstream Bio, Inc.
Healthcare
|
Held | 2,459,703 | $22,137,327 | 6.30% | |
| CAMP |
Camp4 Therapeutics Corp
Healthcare
|
Reduced | 2,190,920 | $9,661,957 | 2.75% |